Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Reemergence of DENV-3III_C.1 and emergence of DENV-3III_B.3.2 in Ecuador: multiple introductions and dispersal patterns, 2022-2026.

Created on 18 Oct 2026

Authors

Sully Márquez, Lizeth Salazar, Gabriela Echeverría-Garcés, Diana Gutiérrez-Pallo, Gabriel Trueba, Joseph N S Eisenberg, Josefina Coloma, Andrés Carrazco-Montalvo

Published in

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. Pages 109189. Oct 17, 2026. Epub Oct 17, 2026.

Abstract

We characterized the reemergence of DENV-3III_C.1, the emergence of DENV-3III_B.3.2, and their phylogeographic spread in Ecuador during 2022-2026 through integrated epidemiologic and genomic surveillance. Lineage DENV-3III_C.1 formed a monophyletic Ecuadorian cluster closely related to Colombian viruses. The earliest sampled Ecuadorian sequence was detected in Esmeraldas, compatible with a possible introduction across the northern border followed by within-country dissemination. Lineage DENV-3III_B.3.2 comprised multiple Ecuadorian clades related to viruses from Colombia, Cuba, and the United States (travel-associated), consistent with independent introductions followed by geographic expansion. These findings reveal distinct transmission histories and support strengthened genomic surveillance at border crossings and other key points of entry.

PMID:
42892551
Bibliographic data and abstract were imported from PubMed on 18 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 22
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement